Navigation Links
Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
Date:4/29/2008

nd development 14,868 22,554

Selling, general and administrative 8,321 15,840

Restructuring charges 260 ----

Total operating expenses 23,844 38,464

Loss from operations (21,800) (13,658)

Investment and other income, net 939 1,978

Loss before income taxes (20,861) (11,680)

Income tax benefit 401 111

Net loss $(20,460) $(11,569)

Basic and diluted net loss per share: ($0.36) ($0.21)

Shares used in calculation of basic and diluted

net loss per share: 56,274 56,126

(1) Stock-based compensation expenses included in

operating expenses amounted to approximately:

Research and development $660 $1,168

Selling, general and administrative 880 1,237

IDENIX PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS)

(UNAUDITED)

March 31, December 31,

2008 2007

ASSETS

Cash and cash equivalents $54,613 $48,260

Marketable securities 30,947 39,862

Receivables from related party 940 11,196

Other current assets 3,440 4,401

Total current assets 89,940 103,719

Intangible assets, net 13,258 13,548<
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
2. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
3. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
4. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
5. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
6. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
7. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
9. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
10. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
11. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2008)...., Aug. 19 /- Particle Sciences Inc. ... polymers) development and,pilot production capabi...rusion and injection molding line. The core of the...ding extruder and Nissei 20T injection,molder, ena...lymeric,devices. This addition gives Particle Scie...
(Date:8/19/2008)...nn., Aug. 19 /- VION,PHARMA...y that it had,entered into an agreement with the D...y Oncology (the "HOVON") to conduct a clinical tri...h standard remission-induction,therapy in patients...enous,leukemia (AML) and high-risk myelodysplasia ...
(Date:8/18/2008)...g. 18 /- The next time you consider p...t might be worth counting sheep,instead. A senior ... San,Diego, Calif. has found evidence that taking ...skin cancer., Daniel F. Kripke, M.D.,s article, b...g pills and cancer, has just been published in the...
(Date:8/18/2008)...rael, August 18 /- Oramed,P....oramed.com ), a developer,of oral delivery system...en,Label Study to Assess the Safety, Pharmacokinet...sulin Formulations in Healthy,Subjects," has been ...l,Meeting of the European Association for the Stud...
Breaking Medicine Technology:Particle Sciences Expands Its Combination Product Capabilities 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Prescription Sleeping Pill Use Tied to Cancer 2Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 1Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 2Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 3Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 4Addition of INTEGRILIN 28R 29 28Eptifibatide 29 to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Co 760 5For migrating sparrows kids have a compass but adults have the map 1116 1For migrating sparrows kids have a compass but adults have the map 1116 2Breastfeeding boost IQ in infants with helpful genetic variant 1115 1Breastfeeding boost IQ in infants with helpful genetic variant 1115 22007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 12007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation 5569 2
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...test on breast-feeding, there is no hard and fast ...Most young mothers would be more// than glad to en... upright while breast feeding, can prove too painf...Take the case of Nicola Adolphe. Nicola accordingl...
... South Dakota is now infusing roasted sunflower ...und in energy drinks//, to provide players and oth...y awake. The product, which has been under develo... Dakota and Kansas and shipped to the company’s (D...
...ut testosterone cream for enhancing sexual desire ...ctive, a new study// conducted by Mayo clinic has ... survivors. As an extension to a previous study wh...herapy and increased sex drive in women with suffi...
...do not get training posts through the flawed Medic...further misery because the government// is stallin..., the BMA warns. Latest figures show that 34,250 ...training posts in the UK. The government has so fa...
Other Medicine News:Health News:New Research Promises To Take The Pain Off Breast Feeding 2Health News:New Research Promises To Take The Pain Off Breast Feeding 3Health News:Caffeinated Sunflower Seeds To Hit The Market 2Health News:Junior Doctors Facing More Misery Because of Contract Deadlock: BMA 2
Angled for temporal approach. Solid 14 mm blades. Dull finish.
Solid 4 mm blades. Locking thumb. Dull finish. Holes in bar decrease weight of speculum.
Open 11 mm blades. Polished finish.
Closed wire 5 mm blade with a wing tip twist giving the surgeon better on-axis accessibility.
Medicine Products: